Fr. 170.00

Histone Deacetylase Inhibitors as Cancer Therapeutics

English · Hardback

Shipping usually within 3 to 5 weeks

Description

Read more

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."

List of contents

      1. Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins
      2. Mechanisms of Resistance to Histone Deacetylase Inhibitors
      3. HDAC Inhibitors: Roles of DNA Damage and Repair
      4. HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer
      5. Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity
      6. Histone Deacetylase Inhibitors and Rational Combination Therapies
      7. HDAC Inhibitors and Chaperone Function

Product details

Assisted by Steven Grant (Editor)
Publisher Academic Press
 
Languages English
Product format Hardback
Released 14.12.2012
 
EAN 9780123943873
ISBN 978-0-12-394387-3
Dimensions 152 mm x 17 mm x 229 mm
Weight 549 g
Series Advances in Cancer Research
Subjects Natural sciences, medicine, IT, technology > Medicine

Microbiology (non-medical), SCIENCE / Life Sciences / Genetics & Genomics, SCIENCE / Life Sciences / Microbiology, Genetics (non-medical)

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.